Krystal Biotech shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Krystal Biotech
Tip: Access up to 7 years of quarterly data
All positions including Krystal Biotech held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Krystal Biotech by Ubs Global Asset Management Americas
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $2.5M | 20k | 124.06 |
2023-09-30 | $2.4M | 20k | 116.00 |
2023-06-30 | $1.3M | 17k | 80.06 |
2023-03-31 | $1.3M | 17k | 80.06 |
2022-12-31 | $1.2M | 16k | 79.22 |
2022-09-30 | $1.1M | 16k | 69.70 |
2022-06-30 | $999k | 15k | 65.66 |
2022-03-31 | $1.0M | 15k | 66.54 |
2021-12-31 | $713k | 10k | 69.95 |
2021-09-30 | $455k | 8.7k | 52.21 |
2021-06-30 | $592k | 8.7k | 68.00 |
2021-03-31 | $722k | 9.4k | 77.04 |
2020-12-31 | $459k | 11k | 43.05 |
2020-09-30 | $459k | 11k | 43.05 |
2020-06-30 | $224k | 5.4k | 41.42 |
2020-03-31 | $254k | 5.9k | 43.24 |
2019-12-31 | $227k | 4.1k | 55.38 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas